Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05798897
Title Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma (APOLLO)
Acronym APOLLO
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Marker Therapeutics, Inc.
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.